Literature DB >> 21581375

2-[4-(4,5-Dihydro-1H-pyrrol-2-yl)phen-yl]-4,5-dihydro-1H-imidazole.

Reza Kia, Hoong-Kun Fun, Hadi Kargar.   

Abstract

The mol-ecule of the title compound, C(12)H(14)N(4), lies about a crystallographic inversion centre. The five- and six-membered rings are twisted from each other, forming a dihedral angle of 18.06 (7)°. In the crystal structure, neighbouring mol-ecules are linked by inter-molecular N-H⋯N hydrogen bonds into one-dimensional infinite chains forming 18-membered rings with R(2) (2)(18) motifs. The crystal structure is further stabilized by weak inter-molecular π-π stacking [centroid-centroid distance = 3.8254 (6) Å] and C-H⋯π inter-actions.

Entities:  

Year:  2008        PMID: 21581375      PMCID: PMC2960053          DOI: 10.1107/S160053680803818X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For details of hydrogen-bond motifs, see: Bernstein et al. (1995 ▶). For a related structure and synthesis, see: Stibrany et al. (2004 ▶). For applications, see: Blancafort (1978 ▶); Chan (1993 ▶); Vizi (1986 ▶); Li et al. (1996 ▶); Ueno et al. (1995 ▶); Corey & Grogan (1999 ▶).

Experimental

Crystal data

C12H14N4 M = 214.27 Triclinic, a = 4.8863 (2) Å b = 5.1472 (2) Å c = 10.2295 (4) Å α = 104.414 (2)° β = 93.885 (2)° γ = 94.207 (2)° V = 247.52 (2) Å3 Z = 1 Mo Kα radiation μ = 0.09 mm−1 T = 100.0 (1) K 0.56 × 0.17 × 0.15 mm

Data collection

Bruker SMART APEXII CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2005 ▶) T min = 0.950, T max = 0.986 4616 measured reflections 1296 independent reflections 1208 reflections with I > 2σ(I) R int = 0.026

Refinement

R[F 2 > 2σ(F 2)] = 0.041 wR(F 2) = 0.116 S = 1.07 1296 reflections 101 parameters All H-atom parameters refined Δρmax = 0.42 e Å−3 Δρmin = −0.24 e Å−3 Data collection: APEX2 (Bruker, 2005 ▶); cell refinement: APEX2; data reduction: SAINT (Bruker, 2005 ▶); program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2003 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S160053680803818X/tk2331sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S160053680803818X/tk2331Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C12H14N4Z = 1
Mr = 214.27F000 = 114
Triclinic, P1Dx = 1.437 Mg m3
Hall symbol: -P 1Melting point: 312 K
a = 4.8863 (2) ÅMo Kα radiation λ = 0.71073 Å
b = 5.1472 (2) ÅCell parameters from 3789 reflections
c = 10.2295 (4) Åθ = 2.5–30.3º
α = 104.414 (2)ºµ = 0.09 mm1
β = 93.885 (2)ºT = 100.0 (1) K
γ = 94.207 (2)ºBlock, colourless
V = 247.522 (17) Å30.56 × 0.17 × 0.15 mm
Bruker SMART APEXII CCD area-detector diffractometer1296 independent reflections
Radiation source: fine-focus sealed tube1208 reflections with I > 2σ(I)
Monochromator: graphiteRint = 0.026
T = 100.0(1) Kθmax = 29.0º
φ and ω scansθmin = 4.1º
Absorption correction: multi-scan(SADABS; Bruker, 2005)h = −6→6
Tmin = 0.950, Tmax = 0.986k = −6→6
4616 measured reflectionsl = −13→13
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.041All H-atom parameters refined
wR(F2) = 0.116  w = 1/[σ2(Fo2) + (0.0717P)2 + 0.0714P] where P = (Fo2 + 2Fc2)/3
S = 1.07(Δ/σ)max < 0.001
1296 reflectionsΔρmax = 0.42 e Å3
101 parametersΔρmin = −0.24 e Å3
Primary atom site location: structure-invariant direct methodsExtinction correction: none
Experimental. The low-temperature data was collected with the Oxford Cyrosystem Cobra low-temperature attachment.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
N10.99649 (17)0.02202 (18)0.30177 (9)0.0140 (2)
N21.05027 (18)0.42785 (18)0.25064 (9)0.0161 (2)
C11.2376 (2)0.1595 (2)0.39310 (10)0.0148 (2)
C21.2547 (2)0.4433 (2)0.36664 (10)0.0158 (2)
C30.92585 (19)0.1869 (2)0.21989 (10)0.0124 (2)
C40.70754 (19)0.08912 (19)0.10716 (10)0.0124 (2)
C50.6787 (2)0.2263 (2)0.00581 (10)0.0138 (2)
C60.5270 (2)−0.1391 (2)0.09997 (10)0.0135 (2)
H1A1.402 (3)0.062 (3)0.3667 (15)0.020 (3)*
H1B1.212 (3)0.169 (3)0.4906 (16)0.024 (4)*
H2A1.443 (3)0.498 (3)0.3429 (16)0.026 (4)*
H2B1.214 (3)0.587 (3)0.4488 (15)0.020 (3)*
H50.802 (3)0.383 (3)0.0096 (16)0.025 (4)*
H60.537 (3)−0.239 (3)0.1687 (15)0.020 (3)*
H1N10.989 (3)−0.151 (4)0.2656 (17)0.029 (4)*
U11U22U33U12U13U23
N10.0135 (4)0.0131 (4)0.0147 (4)−0.0009 (3)−0.0033 (3)0.0041 (3)
N20.0147 (4)0.0150 (4)0.0177 (5)−0.0009 (3)−0.0044 (3)0.0047 (3)
C10.0125 (4)0.0157 (5)0.0153 (5)−0.0008 (3)−0.0030 (3)0.0037 (4)
C20.0144 (5)0.0153 (5)0.0167 (5)−0.0011 (4)−0.0038 (3)0.0041 (4)
C30.0102 (4)0.0142 (5)0.0130 (4)0.0015 (3)0.0006 (3)0.0036 (3)
C40.0098 (4)0.0134 (5)0.0133 (4)0.0009 (3)0.0000 (3)0.0025 (3)
C50.0109 (4)0.0143 (5)0.0159 (5)−0.0009 (3)0.0001 (3)0.0041 (3)
C60.0128 (4)0.0140 (5)0.0142 (5)0.0002 (3)0.0003 (3)0.0049 (3)
N1—C31.3780 (13)C2—H2B1.015 (15)
N1—C11.4700 (12)C3—C41.4787 (13)
N1—H1N10.874 (18)C4—C51.3973 (14)
N2—C31.2944 (13)C4—C61.4000 (14)
N2—C21.4808 (12)C5—C6i1.3881 (13)
C1—C21.5479 (14)C5—H50.961 (16)
C1—H1A0.997 (14)C6—C5i1.3881 (13)
C1—H1B1.004 (16)C6—H60.970 (15)
C2—H2A1.006 (16)
C3—N1—C1107.38 (8)C1—C2—H2B112.1 (9)
C3—N1—H1N1118.4 (11)H2A—C2—H2B106.8 (12)
C1—N1—H1N1119.9 (10)N2—C3—N1116.89 (9)
C3—N2—C2106.43 (8)N2—C3—C4123.28 (9)
N1—C1—C2102.00 (8)N1—C3—C4119.77 (9)
N1—C1—H1A108.9 (8)C5—C4—C6118.99 (9)
C2—C1—H1A112.8 (9)C5—C4—C3119.82 (9)
N1—C1—H1B112.3 (9)C6—C4—C3121.19 (9)
C2—C1—H1B111.4 (9)C6i—C5—C4120.61 (9)
H1A—C1—H1B109.3 (12)C6i—C5—H5119.7 (9)
N2—C2—C1106.30 (8)C4—C5—H5119.6 (9)
N2—C2—H2A109.2 (9)C5i—C6—C4120.40 (9)
C1—C2—H2A111.9 (9)C5i—C6—H6117.6 (9)
N2—C2—H2B110.6 (8)C4—C6—H6122.0 (9)
C3—N1—C1—C29.79 (10)N1—C3—C4—C5−165.14 (9)
C3—N2—C2—C13.06 (11)N2—C3—C4—C6−161.93 (10)
N1—C1—C2—N2−7.84 (10)N1—C3—C4—C615.11 (14)
C2—N2—C3—N13.71 (12)C6—C4—C5—C6i0.46 (16)
C2—N2—C3—C4−179.17 (8)C3—C4—C5—C6i−179.29 (8)
C1—N1—C3—N2−9.24 (12)C5—C4—C6—C5i−0.46 (16)
C1—N1—C3—C4173.53 (8)C3—C4—C6—C5i179.29 (8)
N2—C3—C4—C517.82 (14)
D—H···AD—HH···AD···AD—H···A
N1—H1N1···N2ii0.87 (2)2.18 (2)3.0060 (13)158.1 (15)
C2—H2B···Cg1iii1.015 (15)2.980 (15)3.8882 (11)149.6 (11)
Table 1

Hydrogen-bond geometry (Å, °)

Cg1 is the centroid of the N1/C1/C2/N2/C3 imidazoline ring.

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1N1⋯N2i0.87 (2)2.18 (2)3.0060 (13)158.1 (15)
C2—H2BCg1ii1.015 (15)2.980 (15)3.8882 (11)149.6 (11)

Symmetry codes: (i) ; (ii) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Enantioselective synthesis of alpha-amino nitriles from N-benzhydryl imines and HCN with a chiral bicyclic guanidine as catalyst.

Authors:  E J Corey; M J Grogan
Journal:  Org Lett       Date:  1999-07-15       Impact factor: 6.005

Review 3.  Compounds acting on alpha 1- and alpha 2- adrenoceptors: agonists and antagonists.

Authors:  E S Vizi
Journal:  Med Res Rev       Date:  1986 Oct-Dec       Impact factor: 12.944

Review 4.  Role of alpha 2-adrenoceptors and imidazoline-binding sites in the control of insulin secretion.

Authors:  S L Chan
Journal:  Clin Sci (Lond)       Date:  1993-12       Impact factor: 6.124

5.  Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis.

Authors:  M Ueno; K Imaizumi; T Sugita; I Takata; M Takeshita
Journal:  Int J Immunopharmacol       Date:  1995-07
  5 in total
  6 in total

1.  2-(3-Chloro-phen-yl)-4,5-dihydro-1H-imidazole.

Authors:  Reza Kia; Hoong-Kun Fun; Hadi Kargar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-17

2.  2-p-Tolyl-4,5-dihydro-1H-imidazole.

Authors:  Reza Kia; Hoong-Kun Fun; Hadi Kargar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-11

3.  2-(4,5-Dihydro-1H-imidazol-2-yl)-pyridine.

Authors:  Reza Kia; Hoong-Kun Fun; Hadi Kargar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-19

4.  2-(2-Thien-yl)-4,5-dihydro-1H-imidazole.

Authors:  Reza Kia; Hoong-Kun Fun; Hadi Kargar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-14

5.  2-(4-Methoxy-phen-yl)-4,5-dihydro-1H-imidazole.

Authors:  Reza Kia; Hoong-Kun Fun; Hadi Kargar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-19

6.  2-(3,4-Dimeth-oxy-phen-yl)-1H-benzimidazole.

Authors:  Aliakbar Dehno Khalaji; Alireza Foroghnia; Mohammad Ali Khalilzadeh; Karla Fejfarová; Michal Dušek
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.